Pharmaceutical composition for treating type 2 diabetes

A technology of type 2 diabetes and composition, applied in the field of pharmaceutical composition, which can solve problems such as high price and unsatisfactory efficiency

Inactive Publication Date: 2015-01-14
WUXI XINDA MEDICAL DEVICE
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] However, in the prior art, the drugs for the treatment of type 2 diabetes are often expensive and the efficiency is often unsatisfactory.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] A pharmaceutical composition for treating type 2 diabetes, characterized in that it comprises a therapeutically effective amount of 1'-(1H-indazole-5-carbonyl)-1-isopropyl-4,6-dihydrospiro[ind Azole-5,4'-piperidin]-7(1H)-one, and a therapeutically effective amount of 4-[5-cyano-4-({2-fluoro-4-[1-(2-hydroxyethyl )-1H-tetrazol-5-yl]phenoxy}methyl)-1H-pyrazol-1-yl]piperidine-1-carboxylic acid isopropyl ester, the mass ratio of the two is 1:1.

[0020] Experiments have proved that the combined use of the two drugs can effectively treat type 2 diabetes, and while treating type 2 diabetes, it can also treat accompanying symptoms such as hypertension and diabetes.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a pharmaceutical composition for treating type 2 diabetes. The pharmaceutical composition contains a therapeutically-effective amount of 1'-(1H-indazol-5-carbonyl)-1-isopropyl-4,6-dihydrospiro[indazol-5,4'-piperidine]-7(1H)-one and a therapeutically-effective amount of 4-[5-cyano-4-({2-fluoro-4-[1-(2-hydroxyethyl)-1H-tetrazol-5-yl]phenoxy}methyl)-1H-pyrazol-1-yl]piperidin-1-isopropyl formate which have the mass ratio of (3: 1) to (1: 3). The pharmaceutical composition can be used for effectively treating the type 2 diabetes.

Description

technical field [0001] The invention relates to a pharmaceutical composition, in particular to a pharmaceutical composition for treating type 2 diabetes. Background technique [0002] Diabetes (diabetes) is a sugar, protein, A series of metabolic disorder syndromes including fat, water and electrolytes, clinically characterized by hyperglycemia, polyuria, polydipsia, polyphagia, weight loss, etc. Blood sugar) Once it is not well controlled, it will cause complications, leading to failure and lesions of the kidneys, eyes, feet and other parts, and it cannot be cured. [0003] Patients with type 2 diabetes do not need to rely on insulin and can use oral hypoglycemic drugs to control blood sugar, also known as non-insulin-dependent diabetes. The so-called "type 2 diabetes" is formed after a long pathological process under the action of various pathogenic factors. Due to the existence of pathogenic factors, the normal blood structure balance is destroyed, and the effectivenes...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/454A61P3/10A61P9/12A61K31/438
CPCA61K31/454A61K31/438
Inventor 王岳荣
Owner WUXI XINDA MEDICAL DEVICE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products